BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 34195785)

  • 1. Increased sTREM-1 plasma concentrations are associated with poor clinical outcomes in patients with COVID-19.
    de Nooijer AH; Grondman I; Lambden S; Kooistra EJ; Janssen NAF; Kox M; Pickkers P; Joosten LAB; van de Veerdonk FL; Derive M; Gibot S; Netea MG;
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34195785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. sTREM-1 Predicts Disease Severity and Mortality in COVID-19 Patients: Involvement of Peripheral Blood Leukocytes and MMP-8 Activity.
    da Silva-Neto PV; de Carvalho JCS; Pimentel VE; Pérez MM; Toro DM; Fraga-Silva TFC; Fuzo CA; Oliveira CNS; Rodrigues LC; Argolo JGM; Carmona-Garcia I; Neto NT; Souza COS; Fernandes TM; Bastos VAF; Degiovani AM; Constant LF; Ostini FM; Feitosa MR; Parra RS; Vilar FC; Gaspar GG; da Rocha JJR; Feres O; Frantz FG; Gerlach RF; Maruyama SR; Russo EMS; Viana AL; Fernandes APM; Santos IKFM; Bonato VLD; Boechat AL; Malheiro A; Sadikot RT; Dias-Baruffi M; Cardoso CRB; Faccioli LH; Sorgi CA; On Behalf Of The Imunocovid Study Group
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients.
    Gibot S; Lafon T; Jacquin L; Lefevre B; Kimmoun A; Guillaumot A; Losser MR; Douplat M; Argaud L; De Ciancio G; Jolly L; Touly N; Derive M; Malaplate C; Luc A; Baumann C; François B
    Intensive Care Med Exp; 2023 Aug; 11(1):51. PubMed ID: 37574520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated plasma level of soluble triggering receptor expressed on myeloid cells-1 is associated with inflammation activity and is a potential biomarker of thrombosis in primary antiphospholipid syndrome.
    Edel Y; Kliminski V; Pokroy-Shapira E; Oren S; Dortort Lazar A; Pri-Paz Basson Y; Egbaria M; Molad Y
    Arthritis Res Ther; 2019 Jan; 21(1):10. PubMed ID: 30616644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis.
    Gibot S; Cravoisy A; Kolopp-Sarda MN; Béné MC; Faure G; Bollaert PE; Levy B
    Crit Care Med; 2005 Apr; 33(4):792-6. PubMed ID: 15818107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of sTREM-1 and Presepsin (sCD14-ST) as Diagnostic and Prognostic Markers of Sepsis.
    Chen M; Zhu Y
    Clin Lab; 2020 Apr; 66(4):. PubMed ID: 32255294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating sTREM-1 as a predictive biomarker of pediatric multisystemic inflammatory syndrome (MIS-C).
    Gonçalves GS; Correa-Silva S; Zheng Y; Avelar I; Montenegro MM; Ferreira AEF; Bain V; Fink TT; Suguita P; Astley C; Lindoso L; Martins F; Matsuo OM; Ferreira JCOA; Firigato I; de Toledo Gonçalves F; Fernanda B Pereira M; Artur A da Silva C; Carneiro-Sampaio M; Marques HHS; Palmeira P
    Cytokine; 2023 Jan; 161():156084. PubMed ID: 36403563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships Between Age, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), and Mortality Among Critically Ill Adults: A Cohort Study.
    Sathe NA; Bhatraju PK; Mikacenic C; Morrell ED; Mabrey FL; Liles WC; Wurfel MM
    Shock; 2022 Feb; 57(2):205-211. PubMed ID: 34812186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble TREM-1 Serum Level can Early Predict Mortality of Patients with Sepsis, Severe Sepsis and Septic Shock.
    Jedynak M; Siemiatkowski A; Mroczko B; Groblewska M; Milewski R; Szmitkowski M
    Arch Immunol Ther Exp (Warsz); 2018 Aug; 66(4):299-306. PubMed ID: 29282483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum soluble triggering receptor expressed on myeloid cells-1 in acute respiratory distress syndrome: a prospective observational cohort study.
    Lin MT; Wei YF; Ku SC; Lin CA; Ho CC; Yu CJ
    J Formos Med Assoc; 2010 Nov; 109(11):800-9. PubMed ID: 21126652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department.
    Van Singer M; Brahier T; Ngai M; Wright J; Weckman AM; Erice C; Meuwly JY; Hugli O; Kain KC; Boillat-Blanco N
    J Allergy Clin Immunol; 2021 Jan; 147(1):99-106.e4. PubMed ID: 33045281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of plasma sTREM-1 in patients with severe sepsis receiving early goal-directed therapy and evaluation of its usefulness.
    Jeong SJ; Song YG; Kim CO; Kim HW; Ku NS; Han SH; Choi JY; Kim JM
    Shock; 2012 Jun; 37(6):574-8. PubMed ID: 22395243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. sTREM-1 predicts intensive care unit and 28-day mortality in cancer patients with severe sepsis and septic shock.
    Ravetti CG; Moura AD; Vieira ÉL; Pedroso ÊR; Teixeira AL
    J Crit Care; 2015 Apr; 30(2):440.e7-13. PubMed ID: 25541104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Utility of Soluble TREM-1 in Predicting Mortality and Cardiovascular Events in Patients With Acute Myocardial Infarction.
    Wang YK; Tang JN; Shen YL; Hu B; Zhang CY; Li MH; Chen RZ; Ge JB; Liu XB
    J Am Heart Assoc; 2018 Jun; 7(12):. PubMed ID: 29886421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Plasma Soluble Triggering Receptor Expressed on Myeloid Cells-1 Level in Patients with Acute Coronary Syndrome (ACS): A Biomarker of Disease Severity and Outcome.
    Shiber S; Kliminski V; Orvin K; Sagy I; Vaturi M; Kornowski R; Drescher M; Molad Y
    Mediators Inflamm; 2021; 2021():8872686. PubMed ID: 33814983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble triggering receptor expressed on myeloid cells-1 as a serum biomarker of early neurologic deterioration and prognosis in acute supratentorial intracerebral hemorrhage.
    Gu Y; Deng X; Liang C; Chen Y; Lei H; Zhang Q
    Clin Chim Acta; 2021 Dec; 523():290-296. PubMed ID: 34655609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TREM-1, TREM-2 and their association with disease severity in patients with COVID-19.
    Fan R; Cheng Z; Huang Z; Yang Y; Sun N; Hu B; Hou P; Liu B; Huang C; Liu S
    Ann Med; 2023; 55(2):2269558. PubMed ID: 37848000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. sTREM-1, sIL-2Rα, and IL-6, but not sCD163, might predict sepsis in polytrauma patients: a prospective cohort study.
    Trancă S; Oever JT; Ciuce C; Netea M; Slavcovici A; Petrișor C; Hagău N
    Eur J Trauma Emerg Surg; 2017 Jun; 43(3):363-370. PubMed ID: 27169526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of soluble triggering receptor expressed on myeloid cells-1 elevation in patients admitted to the intensive care unit with sepsis.
    Charles PE; Noel R; Massin F; Guy J; Bollaert PE; Quenot JP; Gibot S
    BMC Infect Dis; 2016 Oct; 16(1):559. PubMed ID: 27729010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.